BONE BIOLOGICS CORP (BBLG) Stock Price, Quote, News and Overview
NASDAQ:BBLG - Nasdaq - US0980705018 - Common Stock - Currency: USD
BBLG Quote, Performance and Key Statistics
0.88
+0.14 (+18.5%)
The current stock price of BBLG is 0.88 USD. In the past month the price increased by 24.81%. In the past year, price decreased by -41.33%.
BBLG Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18 | 327.00B | ||
| AMGN | AMGEN INC | 13.25 | 147.86B | ||
| GILD | GILEAD SCIENCES INC | 14.1 | 135.84B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 114.96B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.87 | 66.38B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 37.94B | ||
| ARGX | ARGENX SE - ADR | 98.52 | 35.31B | ||
| ONC | BEIGENE LTD-ADR | 5.9 | 25.53B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.45B | ||
| NTRA | NATERA INC | N/A | 21.01B | ||
| BIIB | BIOGEN INC | 8.25 | 19.13B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.11B |
Related stock screener links
About BBLG
Company Profile
Bone Biologics Corp. operates as a medical device company. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Company Info
BONE BIOLOGICS CORP
2 Burlington Woods Dr Ste 100
Burlington MASSACHUSETTS US
Employees: 2
Phone: 17815524452
BONE BIOLOGICS CORP / BBLG FAQ
What is the stock price of BONE BIOLOGICS CORP today?
The current stock price of BBLG is 0.88 USD. The price increased by 18.5% in the last trading session.
What is the ticker symbol for BONE BIOLOGICS CORP stock?
The exchange symbol of BONE BIOLOGICS CORP is BBLG and it is listed on the Nasdaq exchange.
On which exchange is BBLG stock listed?
BBLG stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BONE BIOLOGICS CORP stock?
7 analysts have analysed BBLG and the average price target is 16.83 USD. This implies a price increase of 1812.5% is expected in the next year compared to the current price of 0.88. Check the BONE BIOLOGICS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BONE BIOLOGICS CORP worth?
BONE BIOLOGICS CORP (BBLG) has a market capitalization of 2.88M USD. This makes BBLG a Nano Cap stock.
How many employees does BONE BIOLOGICS CORP have?
BONE BIOLOGICS CORP (BBLG) currently has 2 employees.
What are the support and resistance levels for BONE BIOLOGICS CORP (BBLG) stock?
BONE BIOLOGICS CORP (BBLG) has a support level at 0.67 and a resistance level at 0.89. Check the full technical report for a detailed analysis of BBLG support and resistance levels.
Should I buy BONE BIOLOGICS CORP (BBLG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BBLG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BBLG, evaluating the profitability, health, valuation and growth aspects
- BONE BIOLOGICS CORP (BBLG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BONE BIOLOGICS CORP (BBLG) Sales and EPS estimates to see what analysts future expectations are.
- BONE BIOLOGICS CORP (BBLG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BONE BIOLOGICS CORP (BBLG) Insider and Institutional Ownership to learn about the owners and their transactions.
- BONE BIOLOGICS CORP (BBLG) Stock Chart to make your own analysis
- BONE BIOLOGICS CORP (BBLG) Latest news and press-releases to stay up to date.
Does BONE BIOLOGICS CORP (BBLG) stock pay dividends?
BBLG does not pay a dividend.
When does BONE BIOLOGICS CORP (BBLG) report earnings?
BONE BIOLOGICS CORP (BBLG) will report earnings on 2025-08-07, after the market close.
What is the Price/Earnings (PE) ratio of BONE BIOLOGICS CORP (BBLG)?
BONE BIOLOGICS CORP (BBLG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.97).
What is the Short Interest ratio of BONE BIOLOGICS CORP (BBLG) stock?
The outstanding short interest for BONE BIOLOGICS CORP (BBLG) is 2.21% of its float. Check the ownership tab for more information on the BBLG short interest.
BBLG Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BBLG. When comparing the yearly performance of all stocks, BBLG is a bad performer in the overall market: 85.95% of all stocks are doing better.
BBLG Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BBLG. While BBLG has a great health rating, there are worries on its profitability.
BBLG Financial Highlights
Over the last trailing twelve months BBLG reported a non-GAAP Earnings per Share(EPS) of -3.97. The EPS increased by 68.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -189.7% | ||
| ROE | -210.26% | ||
| Debt/Equity | 0 |
BBLG Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to BBLG. The Buy consensus is the average rating of analysts ratings from 7 analysts.